A Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Participants With Lichen Sclerosus
Clinical trial NCT05593445 · COMPLETED
Trial details
- NCT number
- NCT05593445
- Sponsor
- Incyte Corporation
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-11-18
- Primary completion
- 2023-09-01
- Enrollment
- 61
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.